205 related articles for article (PubMed ID: 20833647)
1. Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.
McGaffin KR; Witham WG; Yester KA; Romano LC; O'Doherty RM; McTiernan CF; O'Donnell CP
Cardiovasc Res; 2011 Jan; 89(1):60-71. PubMed ID: 20833647
[TBL] [Abstract][Full Text] [Related]
2. Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.
Witham W; Yester K; O'Donnell CP; McGaffin KR
J Mol Cell Cardiol; 2012 Jul; 53(1):91-100. PubMed ID: 22507542
[TBL] [Abstract][Full Text] [Related]
3. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury.
McGaffin KR; Sun CK; Rager JJ; Romano LC; Zou B; Mathier MA; O'Doherty RM; McTiernan CF; O'Donnell CP
Cardiovasc Res; 2008 Jan; 77(1):54-63. PubMed ID: 18006469
[TBL] [Abstract][Full Text] [Related]
4. Leptin attenuates cardiac apoptosis after chronic ischaemic injury.
McGaffin KR; Zou B; McTiernan CF; O'Donnell CP
Cardiovasc Res; 2009 Jul; 83(2):313-24. PubMed ID: 19233863
[TBL] [Abstract][Full Text] [Related]
5. AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction.
Cieslik KA; Taffet GE; Crawford JR; Trial J; Mejia Osuna P; Entman ML
J Mol Cell Cardiol; 2013 Oct; 63():26-36. PubMed ID: 23871790
[TBL] [Abstract][Full Text] [Related]
6. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
Nam DH; Kim E; Benham A; Park HK; Soibam B; Taffet GE; Kaelber JT; Suh JH; Taegtmeyer H; Entman ML; Reineke EL
FASEB J; 2019 Jan; 33(1):711-721. PubMed ID: 30024790
[TBL] [Abstract][Full Text] [Related]
7. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
8. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.
Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y
J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
12. Brain-Derived Neurotrophic Factor Improves Impaired Fatty Acid Oxidation Via the Activation of Adenosine Monophosphate-Activated Protein Kinase-ɑ - Proliferator-Activated Receptor-r Coactivator-1ɑ Signaling in Skeletal Muscle of Mice With Heart Failure.
Matsumoto J; Takada S; Furihata T; Nambu H; Kakutani N; Maekawa S; Mizushima W; Nakano I; Fukushima A; Yokota T; Tanaka S; Handa H; Sabe H; Kinugawa S
Circ Heart Fail; 2021 Jan; 14(1):e005890. PubMed ID: 33356364
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
14. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
Sasaki H; Asanuma H; Fujita M; Takahama H; Wakeno M; Ito S; Ogai A; Asakura M; Kim J; Minamino T; Takashima S; Sanada S; Sugimachi M; Komamura K; Mochizuki N; Kitakaze M
Circulation; 2009 May; 119(19):2568-77. PubMed ID: 19414638
[TBL] [Abstract][Full Text] [Related]
15. Leptin signaling in the failing and mechanically unloaded human heart.
McGaffin KR; Moravec CS; McTiernan CF
Circ Heart Fail; 2009 Nov; 2(6):676-83. PubMed ID: 19919993
[TBL] [Abstract][Full Text] [Related]
16. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent cardiac function during experimental sepsis: effect of pharmacological activation of AMP-activated protein kinase by AICAR.
Inata Y; Piraino G; Hake PW; O'Connor M; Lahni P; Wolfe V; Schulte C; Moore V; James JM; Zingarelli B
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H826-H837. PubMed ID: 29979626
[TBL] [Abstract][Full Text] [Related]
18. G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart.
Wang Y; Gao E; Lau WB; Wang Y; Liu G; Li JJ; Wang X; Yuan Y; Koch WJ; Ma XL
Circulation; 2015 Apr; 131(16):1392-404. PubMed ID: 25696921
[TBL] [Abstract][Full Text] [Related]
19. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia.
Ren J; Xu X; Wang Q; Ren SY; Dong M; Zhang Y
J Mol Cell Cardiol; 2016 Apr; 93():18-31. PubMed ID: 26906634
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity.
Hall ME; Smith G; Hall JE; Stec DE
Am J Physiol Regul Integr Comp Physiol; 2012 Dec; 303(12):R1241-50. PubMed ID: 23115124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
